Related Experiment Video
Updated: Aug 9, 2026

Culture of Macrophage Colony-stimulating Factor Differentiated Human Monocyte-derived Macrophages
Published on: June 30, 2016
Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates
Jennifer R Timoshanko1, A Richard Kitching, Timothy J Semple
1Centre for Inflammatory Diseases, Monash University, Department of Medicine, Monash Medical Center, Clayton, 3168 Victoria, Australia. jennifer.timoshanko@med.monash.edu.au
Abstract:
GM-CSF has previously been demonstrated to be important in crescentic glomerulonephritis (GN). As both renal parenchymal cells and infiltrating inflammatory cells produce GM-CSF, their separate contributions to inflammatory renal injury were investigated by creation of two different types of GM-CSF chimeric mice: (1) GM-CSF-deficient (GM-CSF-/-)-->wild-type (WT) chimeras with leukocytes that are unable to produce GM-CSF and (2) WT-->GM-CSF-/- chimeras with deficient renal cell GM-CSF expression. Crescentic anti-glomerular basement membrane GN was induced in WT, GM-CSF(-/-)-->WT chimeras, WT-->GM-CSF-/- chimeras, and GM-CSF-/- mice by planting an antigen (sheep globulin) in their glomeruli. WT mice developed severe crescentic GN, whereas GM-CSF-/- were protected from development of disease. Glomerular T cell recruitment, CD40+ glomerular cells, and renal IFN-gamma and TNF expression were similar in both chimeras and WT mice but significantly reduced in GM-CSF-/- mice, indicating that either leukocyte or renal sources of GM-CSF are sufficient to drive these aspects of the inflammatory response. Restricted expression of GM-CSF revealed a major role for renal cell-derived GM-CSF but a minor role for leukocyte-derived GM-CSF in the formation of cellular crescents; glomerular MHC II expression; serum creatinine; and monocyte chemoattractant protein-1, vascular cellular adhesion molecule, and IL-1beta expression. Glomerular macrophage accumulation, proteinuria, and interstitial infiltrate were equivalent in both chimeric groups but intermediate between WT and GM-CSF-/-, indicating that both sources are required for the full development of glomerular injury in crescentic GN.
Insights
Granulocyte-macrophage colony-stimulating factor (GM-CSF) from kidney cells, not immune cells, is key for crescent formation in glomerulonephritis. Both sources are needed for full injury development.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Granulocyte-macrophage colony-stimulating factor (GM-CSF) plays a role in crescentic glomerulonephritis (GN).
- Both kidney cells and inflammatory cells produce GM-CSF, but their distinct roles in renal injury are unclear.
Purpose of the Study:
- To investigate the separate contributions of renal parenchymal and inflammatory cells to GM-CSF-driven renal injury in crescentic GN.
- To determine the specific roles of leukocyte-derived versus renal cell-derived GM-CSF in the pathogenesis of GN.
Main Methods:
- Creation of two GM-CSF chimeric mouse models: GM-CSF-/- --> Wild-Type (WT) and WT --> GM-CSF-/-.
- Induction of crescentic anti-glomerular basement membrane GN in WT, GM-CSF-/-, and chimeric mice.
- Analysis of inflammatory markers, cellular infiltration, and kidney injury indicators.
Main Results:
- WT mice developed severe crescentic GN; GM-CSF-/- mice were protected.
- Renal cell-derived GM-CSF was crucial for crescent formation, glomerular MHC II, serum creatinine, and inflammatory mediators.
- Leukocyte-derived GM-CSF had a minor role in these aspects.
- Both renal and leukocyte GM-CSF were required for macrophage accumulation, proteinuria, and interstitial infiltrate.
Conclusions:
- Renal cell-derived GM-CSF is the primary driver of key inflammatory and injury markers in crescentic GN.
- Leukocyte-derived GM-CSF contributes to overall glomerular injury but is not essential for initial crescent formation.
- Targeting renal cell GM-CSF may be a therapeutic strategy for GN.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells

